Brostallicin
Names | |
---|---|
IUPAC name
4-[(2-Bromoacryloyl)amino]-N-{5-[(5-{[5-({2-[(diaminomethylene)amino]ethyl}carbamoyl)-1-methyl-1H-pyrrol-3-yl]carbamoyl}-1-methyl-1H-pyrrol-3-yl)carbamoyl]-1-methyl-1H-pyrrol-3-yl}-1-methyl-1H-pyrrole-2-carboxamide | |
Identifiers | |
3D model (Jmol) | Interactive image |
ChemSpider | 5293605 |
PubChem | 6918408 |
| |
| |
Properties | |
C30H35BrN12O5 | |
Molar mass | 723.59 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Brostallicin is a chemical compound being studied in the treatment of cancer. It is an alkylating agent that binds DNA.[1]
References
- ↑ Brostallicin entry in the NCI Dictionary of Cancer Terms
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".
This article is issued from Wikipedia - version of the 7/7/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.